The Russian drug against blood clots is being prepared to complete clinical trials in Russia, the drug Angipur is being developed, which should prevent the formation of blood clots. Its effect is aimed at weddings: the drug prevents them from sticking together, thus reducing the risk of blood vessel blockage. According to one of the developers Victor Sirotenko, the drug is designed to be used, in particular, for myocardial infarction and the installation of stents to restore blood flow in the arteries of the heart. Work on Angipur has been going on for 10 years. Now the drug is moving to the final stage of clinical studies. The development should also be an alternative to imported drugs: foreign materials and equipment are not required for its production.

The Russian drug against blood clots is being prepared to complete clinical trials in Russia, the drug Angipur is being developed, which should prevent the formation of blood clots. Its effect is aimed at weddings: the drug prevents them from sticking together, thus reducing the risk of blood vessel blockage. According to one of the developers Victor Sirotenko, the drug is designed to be used, in particular, for myocardial infarction and the installation of stents to restore blood flow in the arteries of the heart. Work on Angipur has been going on for 10 years. Now the drug is moving to the final stage of clinical studies. The development should also be an alternative to imported drugs: foreign materials and equipment are not required for its production.